With the development of the blood coagulation industry, more and more IVD companies have joined it and actively expanded the related services.

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China. Latest news

Grifols Diagnostic Solutions announced Thursday its Procelix Panther System featuring Automation Ready Technology (ART) received approval from the US Food and Drug Administration.

Guardant Health reported after the close of the market on Thursday that its first quarter 2019 revenues were up 84 percent year over year.

Grail said today that it has raised $390 million in a Series D financing round, which included new investors Public Sector Pension Investment Board, Canada Pension Plan Investment Board, and two other undisclosed contributors.

A new consortium spearheaded by the New York Genome Center aims to foster and organize genomic COVID-19 research in the New York metropolitan area. With approximately $2.5 million in philanthropy funding to start, the COVID-19 Genomics Rese

Genomic epidemiology papers from two independent teams are exploring potential sources of recent SARS-CoV-2 introductions to Chinas Guangdong province and to Connecticut, respectively, revealing some of the complex dynamics of the coronavir

In the months since SARS-CoV-2 emerged and began spreading, researchers have been attempting to collect new data to understand the virus and COVID-19 disease it causes. But they have also been digging into sequence and gene expression data

Two months into the COVID-19 pandemic, the number of SARS-CoV-2 molecular diagnostic tests across the US remains woefully inadequate. According to the COVID Tracking Project, a volunteer effort to track testing across the country headed by

A new study launched by scientists at Hannover Medical School (MHH) in Germany is determined to find out why patients respond differently to COVID-19. With the help of industry partners including Bionano Genomics, Genoox, Rescale, and Amazo

South Korean molecular diagnostics firm Seegene announced after the close of the market on Tuesday that the US Food and Drug Administration has granted Emergency Use Authorization for the firms Allplex 2019-nCoV Assay, a real-time RT-PCR te

Exact Sciences reported on Tuesday after the close of the market that its preliminary first quarter revenues are expected to rise about 115 percent, despite the negative impact of the COVID-19 pandemic on orders for its Cologuard colorectal